TISSUETECH
TissueTech is an innovative technology company that uses products derived from human amniotic and umbilical cord tissues. Its medical technology platform markets innovative amniotic and umbilical cord-based products, thereby enabling physicians to avail of enhanced regenerative healing technology in eye care, wound care, and orthopedics. Tissuetech was founded in 2001 and is headquartered in Miami, Florida.
TISSUETECH
Industry:
Biotechnology Health Care Medical Medical Device Pharmaceutical
Founded:
2001-01-01
Address:
Miami, Florida, United States
Country:
United States
Website Url:
http://www.tissuetech.com
Total Employee:
251+
Status:
Active
Contact:
786-817-6690
Email Addresses:
[email protected]
Total Funding:
110.04 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail ReCAPTCHA Microsoft Azure DNS Google Google Cloud Gravity Forms Network Solutions DNS Mimecast
Current Advisors List
Current Employees Featured
Founder
Investors List
Essex Woodlands Healthcare Partners
Essex Woodlands Healthcare Partners investment in Series C - Tissuetech
Ballast Point Ventures
Ballast Point Ventures investment in Series C - Tissuetech
RC Capital
RC Capital investment in Series B - Tissuetech
Ballast Point Ventures
Ballast Point Ventures investment in Series B - Tissuetech
RC Capital
RC Capital investment in Series A - Tissuetech
Ballast Point Ventures
Ballast Point Ventures investment in Series A - Tissuetech
Official Site Inspections
http://www.tissuetech.com
- Host name: 27.203.184.35.bc.googleusercontent.com
- IP address: 35.184.203.27
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Tissuetech"
BioTissue - Crunchbase Company Profile & Funding
BioTissue is an innovative technology company that uses products derived from human amniotic and umbilical cord tissues. Its medical technology platform markets innovative amniotic and …See details»
TissueTech Company Profile - Craft
TissueTech has 5 employees across 2 locations and $110.04 m in total funding,. See insights on TissueTech including office locations, competitors, revenue, financials, executives, …See details»
TISSUETECH AT A GLANCE
%PDF-1.6 %âãÏÓ 50 0 obj > endobj 79 0 obj >/Filter/FlateDecode/ID[]/Index[50 43]/Info 49 0 R/Length 132/Prev 102606/Root 51 0 R/Size 93/Type/XRef/W[1 3 1]>>stream ...See details»
Working At TissueTech: Company Overview and Culture - Zippia
Mar 14, 2024 Organization Type. Private. CEO. Ted Davis. Social Media. TissueTech is an innovative technology company that uses products derived from human amniotic and umbilical …See details»
TissueTech Announces Rebranding, Adopts BioTissue Name …
Mar 8, 2022 TissueTech, Inc.—a pioneer in the clinical application of cryopreserved human birth tissue products to treat ocular surface disease and disorders, chronic wounds, and …See details»
TissueTech Announces Rebranding, Adopts BioTissue Name …
Feb 9, 2022 By adopting the BioTissue name across the entire organization, the company will also reflect that innovative heritage and promise in its surgical business, which was previously …See details»
TissueTech - VentureRadar
"Bio-Tissue, Inc. is the leader in human birth tissue products for use in the treatment of patients with ocular surface disease and disorders. Bio-Tissue is the only provider of cryopreserved …See details»
Tissuetech | CipherBio
Explore Tissuetech's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
TissueTech Announces Rebranding, Adopts BioTissue Name …
Feb 9, 2022 TissueTech, Inc.—a pioneer in the clinical application of cryopreserved human birth tissue products to treat ocular surface disease and disorders, chronic wounds, and …See details»
TissueTech Announces Rebranding, Adopts BioTissue Name …
Feb 9, 2022 MIAMI--(BUSINESS WIRE)-- TissueTech, Inc.a pioneer in the clinical application of cryopreserved human birth tissue products to treat ocular surface disease and disorders, …See details»
TissueTech CEO And Leadership: Executives and Demographics
Nov 18, 2022 Here are further demographic highlights of the leadership team: The TissueTech executive team is 29% female and 71% male.; 59% of the management team is White.; 6% of …See details»
TissueTech CEO and Key Executive Team | Craft.co
TissueTech's President, CEO is Amy Tseng. Other executives include Scheffer C.G. Tseng, Chief Technology Officer; Devin Buckley, Chief Compliance Officer, Corporate Legal Counsel and 2 …See details»
TissueTech Announces Rebranding, Adopts BioTissue Name …
Feb 15, 2022 TissueTech, Inc.—a pioneer in the clinical application of cryopreserved human birth tissue products to treat ocular surface disease and disorders, chronic wounds, and …See details»
BioTissue - Funding, Financials, Valuation & Investors - Crunchbase
BioTissue has a post-money valuation in the range of $100M to $500M as of Jun 27, 2019, according to PrivCo.Sign up for a free trial to view exact valuation and search companies with …See details»
Ted Davis to Succeed Amy Tseng as President and CEO of …
Jan 27, 2022 “I am pleased to transition leadership of the organization to Ted, as I know he will bring new energy, experience and ideas to this next phase of growth for TissueTech.” About …See details»
TissueTech Management Team - CB Insights
Pegasus Biologics is a contract research organization specializing in biopharmaceuticals and DNA vaccines within the biotechnology sector. The company offers services such as analytical …See details»
How TissueTech Managed Growth Virtual Trials And Survived …
Aug 11, 2020 Those patients oftentimes face amputation and a subsequent mortality rate that can be as high as 50 percent in five years. Still, the pandemic forced TissueTech to delay the …See details»
TISSUETECH: Receives Regenerative Medicine Advanced Therapy …
Apr 17, 2020 TissueTech issued the following announcement on April 16. TissueTech, Inc., the pioneer in the development and clinical application of regenerative human birth tissue …See details»
TissueTech Receives Regenerative Medicine Advanced Therapy …
MIAMI, April 16, 2020 /PRNewswire/ -- TissueTech, Inc., the pioneer in the development and clinical application of regenerative human birth tissue products, announced today that the U.S. …See details»